Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Complementary Therapies in Clinical Practice
GLP-1 RISKS (with risk increases) Gastrointestinal Nausea and vomiting: 30% higher GERD (acid reflux): 14% higher Gastritis: 10% higher Noninfectious gastroenteritis: 12% higher Gastroparesis: 7% higher Diverticulosis/diverticulitis: 8% higher Drug-induced pancreatitis: 146% higher Other Systems Hypotension (low blood pressure): 6% higher Syncope (fainting): 6% higher Sleep disturbances: 12% higher Headaches: 10% higher Arthritis: 11% higher Joint pain: 11% higher Tendinitis/synovitis: 10% higher Kidney stones: 15% higher Interstitial nephritis: 6% higher This approach allowed researchers to evaluate the medications effects across 175 different health outcomes everything from heart attacks to headaches
Wegovy has shown remarkable effectiveness in promoting weight loss, with participants in clinical trials experiencing an average weight reduction of around 15% of their initial body weight
doi: 10.1111/j.1463-1326.2010.01355.x 58 GilbertMPMarreMHolstJJGarberABaeresFMMThomsenHet al
